Markets
Buffett
Still Oracle-ing.

The ‘Buffett Indicator’ is going nuts

What is it telling us?

Once upon a time, investors believed that the value of the US stock market was tethered in some fundamental way to the overall productive capacity of the US economy, and the publicly traded companies whose profits depended on American growth.

One of those investors was — and at age 93, still is — Warren Buffett, Chairman and CEO of insurance, investment, and industrial conglomerate Berkshire Hathaway.

That’s just his day job, however. Buffett has long played an unofficial role as American capitalism’s affable, avuncular avatar, with the press and the public seeking out his folksy common sense both when the markets are gripped by speculative fever and when there’s an all-out crisis.

Buffett’s steadying influence flows, in a sense, from his association with value investing, the school of thought we alluded to before, that focuses on the prospect of a company’s earning power and prospective dividends, and ultimately the US economy, as the basis of investment decisions.

Typically, such value investors tend to be somewhat contrarian by nature. In frothy markets, they typically warn investors that that stock prices may be overvalued, and outpacing the ability of companies to produce profits and return money to shareholders. Conversely, when the markets tumble, they tend to see bargains, arguing the investors are too pessimistic about the stability of the US economy and how much money companies stand to make in the future. As Buffett said, “Be fearful when others are greedy, and greedy when others are fearful.”

One of the tools the Oracle of Omaha famously said he looks to in order to tell where we are in such a cycle is the ratio of stock market capitalization — that the total value on paper of the stocks that are publicly traded — as a share of gross domestic product, the most comprehensive gauge of the economy. It’s become known as the “Buffett Indicator.” Here’s a version of it.

Buffett laid out his thinking about this stat in a speech, that was published in Fortune magazine back in late 2001, as the market deflated from the tech stock boom.

The ratio has certain limitations in telling you what you need to know. Still, it is probably the best single measure of where valuations stand at any given moment. And as you can see, nearly two years ago the ratio rose to an unprecedented level. That should have been a very strong warning signal.

Buffett’s well-known avoidance of the tech stock boom-and-bust of the 1990s, was perhaps one of the best calls in an investing career replete with them.

Today — thanks to the technological promise of AI, as well as the hype cycle surrounding it — we’re in another tech boom. And again, at least according to the Buffett Indicator, stocks are pretty clearly overvalued.

That’s not a reason to sell, of course. Globalization has deepened profit-making opportunities for the largest companies so the US economy may no longer be the best denominator. Buffett popularized this metric before China was even a member of the World Trade Organization.

And the market can stay overvalued for a long time, and delivering giant returns to investors as it does. Still, amid all the AI-related excitement, this common sense statistic seems worth keeping an eye on.

More Markets

See all Markets
markets

Spectrum owner Charter Communications is on pace for its worst day ever as broadband numbers and Q1 results disappoint

Cable and broadband company Charter Communications is on pace for its worst-ever trading day on Friday, as investors dump the stock following its Q1 results and forward guidance.

Charter, which owns Spectrum, reported adjusted earnings of $9.17 per share, below Wall Street estimates of $9.96 per share from analysts polled by FactSet. On the company’s earnings call, CFO Jessica Fischer appeared to lower its guidance for full-year revenue per user.

“It’ll be close either way in terms of whether we end up with net growth,” Fischer said.

The company lost 120,000 internet subscribers in the quarter, deeper than the expected 94,800 and double its loss from the same period last year. That news comes one day after Comcast’s earnings provided a bit of optimism for broadband as a category: the company reported Q1 losses of 65,000, significantly improving from 183,000 losses in the same quarter last year. Comcast is down more than 10%, on pace for its worst day since January 2025.

markets

Nvidia poised to snap longest run without a record close since the AI boom began

The stock price of the company responsible for the brains of the AI boom is finally showing some brawn again.

Nvidia, the world’s most valuable company, is poised to close at a record high for the first time since October 29, 2025, on Friday (if it ends above $207.04).

The AI chip trade is on fire, with the Philadelphia Semiconductor Index slated to deliver its 18th consecutive gain as Intel’s robust results and outlook juice the entire ecosystem. Hyperscalers report earnings next week, and their capex guidance can be thought of as the earnings guidance for Nvidia and other AI suppliers for the quarters to come.

This would end Nvidia’s longest stretch without a record close since the unofficial start of the AI boom (when the chip designer delivered blowout quarterly results in May 2023).

(Sorry if I jinx this!)

markets

Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week

Eli Lilly fell on Friday after prescription data for its new weight-loss pill, Foundayo, showed that it’s having a significantly slower rollout than its top competitor.

The pill was prescribed about 3,700 times in its second week, according to IQVIA data cited by Deutsche Bank analysts, compared to the roughly 8,000 they were expecting. Novo Nordisk’s Wegovy pill, which came out in January, hit over 18,000 prescriptions in its second week.

The FDA approved Foundayo on April 1 and shipments began on April 9. Deutsche analysts noted that Lilly’s GLP-1 injections, which currently outsell Novo’s, also had a slower start.

Lilly fell more than 4% after the numbers were released. Novo Nordisk rose more than 5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.